Circana’s Sally Lyons Wyatt walks us through new research from the global consulting firm’s that reveals just how dramatically GLP-1 medications are shifting U.S. consumer eating and purchasing behavior—and how CPG brands and retailers can get ahead of increasing consumer demand. Nutrition and metabolism researcher Kevin Hall unpacks the latest science on ultra-processed foods, explaining why debates over definitions often miss the deeper mechanisms driving excess calorie intake, and explores how food scientists, nutrition researchers, and industry innovators can work together to develop healthier, evidence-based products for the future.
Plus: This episode of Omnivore is brought to you by IFT Membership. It’s where you belong. As a member, you’ll enjoy a global community united by purpose and driven by science ready to make a lasting impact on the global food system. Visit ift.org/join.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Email | Deezer | Anghami | RSS | More